The Value of Fear and Greed
Anonymousrhondamuse.com
Viking Therapeutics Inc (NASDAQ: VKTX ) shares are trading higher on Friday. BMO Capital initiated coverage on the stock with an Outperform rating and a price target of $14 per share. Viking Therapeutics is a health care service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The companys clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta. Viking Therapeutics shares are trading up 3.23% at $7.36 on Friday. The stock has a 52-week range between $8.87 and $3.26. Related Links: Gilead Analysts See Questionable Commercial Opportunity For Coronavirus Candidate Remdesivir Moderna, Lonza Strike Deal To Manufacture Up To 1 Billion Doses Of Coronavirus Vaccine Candidate Annually Latest Ratings for VKTX Jun 2020 BMO Capital Initiates Coverage On Outperform May 2020 Chardan Capital Initiates Coverage On Buy May 2020 B. Riley FBR Maintains Buy View More Analyst Ratings for VKTX View the Latest Analyst Ratings See more from Benzinga Why Viking Therapeutics Is Trading Higher Today © 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. View comments
Navigating Career Uncertainty at 24: A Personal Reflection
A reflection on feeling lost at 24 and the journey toward fulfillment in work and life.